Venture NAV Tracker / Private company
Pelthos Therapeutics
A commercial-stage biopharmaceutical company and Horizon Technology Finance portfolio company.
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Current disclosed marks
One latest disclosed debt mark per fund.
| Fund | Security type | Principal | Fair value | FV / principal | Rate | Maturity | Non-accrual |
|---|---|---|---|---|---|---|---|
| HRZNHorizon Technology Finance Corporation | senior secured loan | $30MMar 31, 2026 · source ↗ | $29.4MMar 31, 2026 · source ↗ | 97.9%Mar 31, 2026 · source ↗ | P+3.75% (10.50% floor, 5.00% ETP)Mar 31, 2026 · source ↗ | Jan 31, 2031Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.